fdaheadlines.com
Exelixis, Inc. (NASDAQ:EXEL) Partner Daiichi Sankyo Company Receives Regulatory Approval for Hypertension Tablets - FDA Headlines
It was good news today in Japan as Exelixis, Inc. (NASDAQ:EXEL) has announced that its collaborator Daiichi Sankyo Company has received approval from Japan’s MHLW (Ministry of Health, Labour and Welfare for the esaxerenone tablets, MINNEBRO 1.25 mg, 2.5 mg, and 5 mg. Good News for Hypertension Patients Patients with hypertension in the country can …